Poll Claire 4/A
4/A · Verona Pharma plc · Filed May 11, 2023
Insider Transaction Report
Form 4/AAmended
Poll Claire
General Counsel
Transactions
- Exercise/Conversion
Ordinary Shares
2023-05-01+8,328→ 1,987,391 total - Exercise/Conversion
Restricted Share Units
2023-05-01−8,328→ 0 totalExp: 2029-03-29→ Ordinary Shares (8,328 underlying)
Footnotes (3)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]Each Restricted Share Unit represented a contingent right to receive one (1) Ordinary Share of the Issuer (which may be represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer) subject to certain time- and performance-based vesting criteria.
- [F3]Consists of (i) 1,641,672 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which are represented by 205,209 ADSs); (ii) 345,712 Ordinary Shares underlying 43,214 ADSs; and (iii) 7 Ordinary Shares.